ENDOPATH ATW35Recalls & reported problems
Ethicon Endo-Surgery, LLC · Endopath ETS Flex Endoscopic Articulating Linear Cutter, Vascular/Thin · Class 2
Data updated Oct 13, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 20705036012327), received between Dec 5, 2017 and Nov 25, 2019 — classified as 2 injuries, 3 malfunctions.
The most frequently reported specific device problem is “Application Program Freezes or Fails to Launch” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Application Program Freezes or Fails to Launch1
- Device Inoperable1
- Difficult to Open or Close1
- Failure to Cut1
- Failure to Form Staple1
- Mechanical Problem1
Patient problems
- No Consequences Or Impact To Patient3
- Blood Loss2
- No Code Available1
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
InjuryNov 25, 2019Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED VIA JOURNAL ARTICLE TITLE: USEFULNESS OF VESSEL-SEALING DEVICES COMBINED WITH CRUSH CLAMPING METHOD FOR HEPATECTOMY: A RETROSPECTIVE COHORT STUDY AUTHORS: ATSUSHI NANASHIMA, TAKAFUMI ABO, JUNICHI ARAI, KATSUNORI TAKAGI, HIROFUMI MATSUMOTO, HIROAKI TAKESHITA, TOMOSHI TSUCHIYA, TAKESHI NAGAYASU CITATION: INTERNATIONAL JOURNAL OF SURGERY 11 (2013) 891-897. DOI: HTTP://DX.DOI.ORG/10.1016/J.IJSU.2013.07.012. THE AIM OF THIS RETROSPECTIVE STUDY WAS TO EVALUATE THE EFFICACY OF THE VESSEL-SEALING DEVICES FOR CONTROLLING BLOOD LOSS, TRANSECTION TIME AND POSTOPERATIVE COMPLICATIONS IN HEPATECTOMY AS A COHORT STUDY. THIS RETROSPECTIVE STUDY INVOLVES 267 PATIENTS WITH LIVER DISEASE WHO UNDERWENT HEPATIC RESECTION BETWEEN 2005 AND SEPTEMBER 2012. ONE HUNDRED EIGHTEEN PATIENTS UNDERWENT THE CONVENTIONAL CRUSH CLAMPING METHOD BETWEEN 2004 AND 2008 (CONTROL GROUP) AND 149 PATIENTS USED VESSEL SEALING DEVICES BETWEEN 2008 AND 2012 (VS GROUP). OF THE 149 PATIENTS IN THE VS GROUP, 120 PATIENTS (80 MALE AND 40 FEMALE) USED LIGASURE DEVICES AND 29 PATIENTS (20 MALE AND 9 FEMALE) USED HARMONIC FOCUS (ETHICON)(N-24; 15 MALE AND 9 FEMALE) OR HARMONIC ACE(ETHICON) (N-5; 5 MALE; MEAN AGE 58±
Patient problems: Blood Loss
MAUDE report 9368802 ↗InjuryNov 5, 2018Difficult to Open or Close
IT WAS REPORTED THAT THE INSTRUMENT, ATW35, WAS PLACED OVER THE VESSEL (AS PART OF NEPHRECTOMY PROCEDURE) AND FIRED. WHEN THE SURGEON TRIED TO OPEN THE INSTRUMENT IT DID NOT OPEN SMOOTHLY. WHEN THE DEVICE WAS REMOVED FROM THE VESSEL THERE WAS BLEEDING FROM SOME KIND OF RIFT."
Patient problems: Blood Loss; No Code Available
MAUDE report 8037806 ↗MalfunctionSep 20, 2018Application Program Freezes or Fails to Launch
IT WAS REPORTED THAT DURING A LAPAROSCOPIC APPENDECTOMY, THE DEVICE WAS LOCKED OUT AT THE FIRST FIRING. ANOTHER DEVICE WAS USED TO COMPLETE THE CASE. THERE WERE NO ADVERSE CONSEQUENCES TO THE PATIENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7895013 ↗MalfunctionJan 2, 2018Device Inoperable
IT WAS REPORTED AT FIRST STAPLING, CLAMP DID NOT FUNCTION. IT LOCKED ON PATIENT BUT WAS REMOVE WITHOUT DIFFICULTIES. USE OF ANOTHER DEVICE. NO PATIENT CONSEQUENCES
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7156574 ↗MalfunctionDec 5, 2017Mechanical Problem; Failure to Form Staple; Failure to Cut
IT WAS REPORTED THAT DURING A LAP NEPHRECTOMY PROCEDURE, THE STAPLER LOCKED OUT PRIOR TO FIRST FIRING. OPENED STAPLER, REMOVED FROM RENAL VEIN, NO STAPLES OR CUT LINE. OPENED LIKE DEVICE WAS FIRED, WORKED AS INDICATED. THERE WERE NO PATIENT CONSEQUENCES REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7084987 ↗
Other STAPLE, IMPLANTABLE devices
- Endo GIA EGIA60AMTCovidien LP · STAPLE, IMPLANTABLE19 deaths10,680 reports
- Endo GIA Ultra EGIAUSTNDCovidien LP · STAPLE, IMPLANTABLE5 deaths9,730 reports
- Signia SIGPHANDLECovidien LP · STAPLE, IMPLANTABLE1 recall3 deaths5,356 reports
- ECHELON FLEX PSEE60AEthicon Endo-Surgery, LLC · STAPLE, IMPLANTABLE1 recall13 deaths3,294 reports
- Endo GIA Ultra EGIAUSHORTCovidien LP · STAPLE, IMPLANTABLE2 deaths3,011 reports
- Endo GIA EGIA45AMTCovidien LP · STAPLE, IMPLANTABLE10 deaths2,965 reports
- Endo GIA Ultra EGIAUXLCovidien LP · STAPLE, IMPLANTABLE2,909 reports
- ENDOPATH ATS45Ethicon Endo-Surgery, LLC · STAPLE, IMPLANTABLE2 deaths2,046 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page